Catalyst Pharmaceuticals Stock Rises 5% On New Share Repurchase Program

Group 1 - Catalyst Pharmaceuticals, Inc. (CPRX) shares increased by 5.38 percent to $20.76, gaining $1.06 following the announcement of a new share repurchase program [1] - The Board of Directors authorized the buyback of up to $200 million of outstanding common stock, scheduled between October 1, 2025, and December 31, 2026 [1] - The stock opened at $20.38 and traded within a range of $20.13 to $22.02, compared to a previous close of $19.70 on the Nasdaq [1] Group 2 - Trading volume reached 2.96 million shares, exceeding the average of 1.47 million shares [2] - Catalyst Pharmaceuticals now trades within a 52-week range of $19.05 to $26.58 [2]